198 related articles for article (PubMed ID: 37024475)
1. PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Shi Y; Niu Y; Yuan Y; Li K; Zhong C; Qiu Z; Li K; Lin Z; Yang Z; Zuo D; Qiu J; He W; Wang C; Liao Y; Wang G; Yuan Y; Li B
Nat Commun; 2023 Apr; 14(1):1932. PubMed ID: 37024475
[TBL] [Abstract][Full Text] [Related]
2. Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A.
Lei Y; Han P; Chen Y; Wang H; Wang S; Wang M; Liu J; Yan W; Tian D; Liu M
Clin Transl Med; 2022 Jan; 12(1):e686. PubMed ID: 35090076
[TBL] [Abstract][Full Text] [Related]
3. PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma.
Wang Y; Wang C; Guan X; Ma Y; Zhang S; Li F; Yin Y; Sun Z; Chen X; Yin H
Adv Sci (Weinh); 2023 Dec; 10(36):e2303812. PubMed ID: 37973560
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis.
Li J; Qin X; Wu R; Wan L; Zhang L; Liu R
J Cell Mol Med; 2020 May; 24(9):5152-5161. PubMed ID: 32222024
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma.
Liao X; Song G; Xu Z; Bu Y; Chang F; Jia F; Xiao X; Ren X; Zhang M; Jia Q
BMC Cancer; 2020 Jan; 20(1):31. PubMed ID: 31931755
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Salmonella carrying siRNA-CD24 improved the effect of oxaliplatin on HCC.
Li B; Zhao T; Shao M; Cai J; Chen S; Chen X; Yang M; Zheng Y; Cui C; Guo S; Yang Z; Ren F; Jia H
Int Immunopharmacol; 2023 Nov; 124(Pt B):111025. PubMed ID: 37827056
[TBL] [Abstract][Full Text] [Related]
8. The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin.
Wang R; Fu Y; Yao M; Cui X; Zhao Y; Lu X; Li Y; Lin Y; He S
FEBS J; 2022 Oct; 289(20):6400-6419. PubMed ID: 35596723
[TBL] [Abstract][Full Text] [Related]
9. LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression.
Zhang J; Hu K; Yang YQ; Wang Y; Zheng YF; Jin Y; Li P; Cheng L
Cell Death Dis; 2020 Sep; 11(9):741. PubMed ID: 32917856
[TBL] [Abstract][Full Text] [Related]
10. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
11. Linc01559 Served as a Potential Oncogene and Promoted Resistance of Hepatocellular Carcinoma to Oxaliplatin by Directly Sponging miR-6783-3p.
Dong S; Fu Y; Yang K; Zhang X; Miao R; Long Y; Liu C
Anticancer Agents Med Chem; 2021; 21(2):278-286. PubMed ID: 32698745
[TBL] [Abstract][Full Text] [Related]
12. HSP90a promotes the resistance to oxaliplatin in HCC through regulating IDH1-induced cell competition.
Wang S; Cheng H; Huang Y; Li M; Gao D; Chen H; Su R; Guo K
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119680. PubMed ID: 38280407
[TBL] [Abstract][Full Text] [Related]
13. SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback.
Liu S; Bu X; Kan A; Luo L; Xu Y; Chen H; Lin X; Lai Z; Wen D; Huang L; Shi M
Cancer Lett; 2022 Mar; 528():16-30. PubMed ID: 34958891
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy.
Ren WW; Li DD; Chen X; Li XL; He YP; Guo LH; Liu LN; Sun LP; Zhang XP
Cell Death Dis; 2018 May; 9(5):547. PubMed ID: 29749374
[TBL] [Abstract][Full Text] [Related]
15. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
16. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
17. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J
Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830
[TBL] [Abstract][Full Text] [Related]
18. PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast.
Zhi R; Wu K; Zhang J; Liu H; Niu C; Li S; Fu L
Cancer Sci; 2023 May; 114(5):1912-1928. PubMed ID: 36637351
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma.
Que KT; Zhou Y; You Y; Zhang Z; Zhao XP; Gong JP; Liu ZJ
J Exp Clin Cancer Res; 2018 Nov; 37(1):268. PubMed ID: 30400960
[TBL] [Abstract][Full Text] [Related]
20. LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.
Ma L; Xu A; Kang L; Cong R; Fan Z; Zhu X; Huo N; Liu W; Xue C; Ji Q; Li W; Chu Z; Kang X; Wang Y; Sun Z; Han Y; Liu H; Gao X; Han J; You H; Zhao C; Xu X
Hepatology; 2021 Dec; 74(6):3213-3234. PubMed ID: 34322883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
